

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 4.93174896 |
| 2 | nucleobase biosynthetic process (GO:0046112) | 4.84435671 |
| 3 | purine nucleobase biosynthetic process (GO:0009113) | 4.73256472 |
| 4 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.57468905 |
| 5 | DNA deamination (GO:0045006) | 4.54789717 |
| 6 | formation of translation preinitiation complex (GO:0001731) | 4.49051494 |
| 7 | proteasome assembly (GO:0043248) | 4.39759293 |
| 8 | DNA strand elongation (GO:0022616) | 4.37609520 |
| 9 | maturation of SSU-rRNA (GO:0030490) | 4.35821816 |
| 10 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.35623676 |
| 11 | DNA replication initiation (GO:0006270) | 4.14164518 |
| 12 | ribosomal large subunit biogenesis (GO:0042273) | 3.91400002 |
| 13 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.87766685 |
| 14 | establishment of viral latency (GO:0019043) | 3.87586344 |
| 15 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.87249278 |
| 16 | telomere maintenance via recombination (GO:0000722) | 3.85022457 |
| 17 | IMP biosynthetic process (GO:0006188) | 3.83975451 |
| 18 | DNA unwinding involved in DNA replication (GO:0006268) | 3.82642361 |
| 19 | ribosome biogenesis (GO:0042254) | 3.81544650 |
| 20 | CENP-A containing nucleosome assembly (GO:0034080) | 3.79471331 |
| 21 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.75379979 |
| 22 | chromatin remodeling at centromere (GO:0031055) | 3.74181324 |
| 23 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.72620888 |
| 24 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.71498987 |
| 25 | DNA replication checkpoint (GO:0000076) | 3.70019149 |
| 26 | ribosome assembly (GO:0042255) | 3.69256826 |
| 27 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.68855732 |
| 28 | cullin deneddylation (GO:0010388) | 3.67704520 |
| 29 | viral transcription (GO:0019083) | 3.65755319 |
| 30 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.64481222 |
| 31 | translational termination (GO:0006415) | 3.63990050 |
| 32 | telomere maintenance via telomere lengthening (GO:0010833) | 3.62119871 |
| 33 | protein deneddylation (GO:0000338) | 3.61882407 |
| 34 | chaperone-mediated protein transport (GO:0072321) | 3.57171535 |
| 35 | rRNA modification (GO:0000154) | 3.57157497 |
| 36 | mitotic recombination (GO:0006312) | 3.55280054 |
| 37 | spliceosomal snRNP assembly (GO:0000387) | 3.53107797 |
| 38 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.52237070 |
| 39 | ribosomal small subunit biogenesis (GO:0042274) | 3.50830652 |
| 40 | mitotic metaphase plate congression (GO:0007080) | 3.49178009 |
| 41 | DNA ligation (GO:0006266) | 3.48241333 |
| 42 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.48050441 |
| 43 | negative regulation of ligase activity (GO:0051352) | 3.48050441 |
| 44 | translational elongation (GO:0006414) | 3.46266917 |
| 45 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.43693541 |
| 46 | ATP synthesis coupled proton transport (GO:0015986) | 3.43472636 |
| 47 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.43472636 |
| 48 | DNA damage response, detection of DNA damage (GO:0042769) | 3.42169755 |
| 49 | pseudouridine synthesis (GO:0001522) | 3.41471363 |
| 50 | establishment of integrated proviral latency (GO:0075713) | 3.40770917 |
| 51 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.39212066 |
| 52 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.39212066 |
| 53 | translational initiation (GO:0006413) | 3.38927689 |
| 54 | rRNA processing (GO:0006364) | 3.37816605 |
| 55 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.36730975 |
| 56 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.36730975 |
| 57 | IMP metabolic process (GO:0046040) | 3.36319071 |
| 58 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.35950583 |
| 59 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.35950583 |
| 60 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.35950583 |
| 61 | folic acid metabolic process (GO:0046655) | 3.35186670 |
| 62 | DNA double-strand break processing (GO:0000729) | 3.33924289 |
| 63 | DNA replication-independent nucleosome assembly (GO:0006336) | 3.32861554 |
| 64 | DNA replication-independent nucleosome organization (GO:0034724) | 3.32861554 |
| 65 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.31842468 |
| 66 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.31465035 |
| 67 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.31465035 |
| 68 | non-recombinational repair (GO:0000726) | 3.31198629 |
| 69 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.31198629 |
| 70 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.26997454 |
| 71 | mitotic nuclear envelope disassembly (GO:0007077) | 3.24980411 |
| 72 | rRNA metabolic process (GO:0016072) | 3.24837580 |
| 73 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 3.24706220 |
| 74 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 3.24706220 |
| 75 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.24153784 |
| 76 | transcription-coupled nucleotide-excision repair (GO:0006283) | 3.24035011 |
| 77 | DNA catabolic process, exonucleolytic (GO:0000738) | 3.24015057 |
| 78 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.23871930 |
| 79 | viral mRNA export from host cell nucleus (GO:0046784) | 3.22780229 |
| 80 | L-serine metabolic process (GO:0006563) | 3.22685527 |
| 81 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.21061973 |
| 82 | cell cycle G1/S phase transition (GO:0044843) | 3.19030548 |
| 83 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.19030548 |
| 84 | spindle checkpoint (GO:0031577) | 3.18567197 |
| 85 | mitotic spindle checkpoint (GO:0071174) | 3.17632494 |
| 86 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 3.17218756 |
| 87 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 3.17218756 |
| 88 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 3.17218756 |
| 89 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 3.17218756 |
| 90 | negative regulation of sister chromatid segregation (GO:0033046) | 3.17218756 |
| 91 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.17178327 |
| 92 | protein localization to chromosome, centromeric region (GO:0071459) | 3.15738332 |
| 93 | regulation of helicase activity (GO:0051095) | 3.15577771 |
| 94 | negative regulation of chromosome segregation (GO:0051985) | 3.14986376 |
| 95 | translation (GO:0006412) | 3.14777614 |
| 96 | cellular component biogenesis (GO:0044085) | 3.14316329 |
| 97 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.13779481 |
| 98 | regulation of mitochondrial translation (GO:0070129) | 3.13663902 |
| 99 | cotranslational protein targeting to membrane (GO:0006613) | 3.12755122 |
| 100 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.10837838 |
| 101 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.10344364 |
| 102 | mitotic sister chromatid segregation (GO:0000070) | 3.09992331 |
| 103 | protein targeting to ER (GO:0045047) | 3.09869381 |
| 104 | positive regulation of ligase activity (GO:0051351) | 3.08769128 |
| 105 | mitochondrial RNA metabolic process (GO:0000959) | 3.05081044 |
| 106 | protein localization to kinetochore (GO:0034501) | 3.05074009 |
| 107 | histone exchange (GO:0043486) | 3.04990796 |
| 108 | termination of RNA polymerase II transcription (GO:0006369) | 3.04245797 |
| 109 | kinetochore organization (GO:0051383) | 3.04092728 |
| 110 | glycine metabolic process (GO:0006544) | 3.04020256 |
| 111 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.03857950 |
| 112 | termination of RNA polymerase III transcription (GO:0006386) | 3.03857950 |
| 113 | deoxyribonucleotide biosynthetic process (GO:0009263) | 3.03533794 |
| 114 | regulation of ligase activity (GO:0051340) | 3.03084330 |
| 115 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 3.02985011 |
| 116 | regulation of mitotic spindle checkpoint (GO:1903504) | 3.02985011 |
| 117 | oxidative phosphorylation (GO:0006119) | 3.02391806 |
| 118 | protein targeting to mitochondrion (GO:0006626) | 3.02387782 |
| 119 | tRNA aminoacylation for protein translation (GO:0006418) | 3.02248820 |
| 120 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.01253886 |
| 121 | 7-methylguanosine mRNA capping (GO:0006370) | 3.00972700 |
| 122 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 3.00478064 |
| 123 | kinetochore assembly (GO:0051382) | 2.97951458 |
| 124 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.97438811 |
| 125 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.97180965 |
| 126 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.97038245 |
| 127 | protein localization to endoplasmic reticulum (GO:0070972) | 2.96020692 |
| 128 | spliceosomal complex assembly (GO:0000245) | 2.95973594 |
| 129 | metaphase plate congression (GO:0051310) | 2.95192530 |
| 130 | RNA capping (GO:0036260) | 2.95047172 |
| 131 | 7-methylguanosine RNA capping (GO:0009452) | 2.95047172 |
| 132 | membrane disassembly (GO:0030397) | 2.94825579 |
| 133 | nuclear envelope disassembly (GO:0051081) | 2.94825579 |
| 134 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.94488003 |
| 135 | tetrahydrofolate metabolic process (GO:0046653) | 2.93818643 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.24242826 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.72929817 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.09622418 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.93218654 |
| 5 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.49952419 |
| 6 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.35199196 |
| 7 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.34714328 |
| 8 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.28843607 |
| 9 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 3.19991403 |
| 10 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 3.10743273 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.10404585 |
| 12 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.09935774 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.02950157 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.95284961 |
| 15 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.61036635 |
| 16 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.59917064 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.58423266 |
| 18 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.54355498 |
| 19 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.51236425 |
| 20 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.41015241 |
| 21 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.38622603 |
| 22 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.33534898 |
| 23 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.32987942 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.30940167 |
| 25 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.23140165 |
| 26 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.17583076 |
| 27 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.06208446 |
| 28 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.06141985 |
| 29 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.98536346 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.97998916 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.97571556 |
| 32 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96271471 |
| 33 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.90821227 |
| 34 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.90477173 |
| 35 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.88417388 |
| 36 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87861754 |
| 37 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.86428410 |
| 38 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85612046 |
| 39 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.83132740 |
| 40 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.80887807 |
| 41 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.78652668 |
| 42 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.76306840 |
| 43 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.74921379 |
| 44 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.71720036 |
| 45 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.70123475 |
| 46 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.68164831 |
| 47 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.64863367 |
| 48 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.63092771 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.58961279 |
| 50 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.58714705 |
| 51 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.53398121 |
| 52 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49245147 |
| 53 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.47084122 |
| 54 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.46690411 |
| 55 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.45901200 |
| 56 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.45874780 |
| 57 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.43797318 |
| 58 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.40906795 |
| 59 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.38159937 |
| 60 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.32351744 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.31883701 |
| 62 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29056885 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28155051 |
| 64 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26726195 |
| 65 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.26541038 |
| 66 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.24692522 |
| 67 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.24640263 |
| 68 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.18941916 |
| 69 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.16589074 |
| 70 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.15550690 |
| 71 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.12016005 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11437832 |
| 73 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.10733476 |
| 74 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.09874250 |
| 75 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.09696881 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.09532230 |
| 77 | * CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.04083088 |
| 78 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.04000241 |
| 79 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.03938502 |
| 80 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03059382 |
| 81 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02841856 |
| 82 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.01838531 |
| 83 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.01431631 |
| 84 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.00694318 |
| 85 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.98019445 |
| 86 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.97453984 |
| 87 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.96892380 |
| 88 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.94548228 |
| 89 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.91459787 |
| 90 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.90210080 |
| 91 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89111663 |
| 92 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.89069745 |
| 93 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.88915394 |
| 94 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.88850274 |
| 95 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.88307697 |
| 96 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.87094967 |
| 97 | EWS_26573619_Chip-Seq_HEK293_Human | 0.87061313 |
| 98 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.86197997 |
| 99 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.84811014 |
| 100 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.83782732 |
| 101 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.83650592 |
| 102 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.82965676 |
| 103 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.82246078 |
| 104 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.82243498 |
| 105 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.81765292 |
| 106 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.81233520 |
| 107 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.79984409 |
| 108 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.79935500 |
| 109 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.79521582 |
| 110 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.77005873 |
| 111 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.69487830 |
| 112 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.69462795 |
| 113 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.67999077 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 5.17794139 |
| 2 | MP0004957_abnormal_blastocyst_morpholog | 4.51823737 |
| 3 | MP0003806_abnormal_nucleotide_metabolis | 4.49373676 |
| 4 | MP0010094_abnormal_chromosome_stability | 4.34648423 |
| 5 | MP0003111_abnormal_nucleus_morphology | 3.81601278 |
| 6 | MP0008058_abnormal_DNA_repair | 3.75724763 |
| 7 | MP0003077_abnormal_cell_cycle | 3.68088252 |
| 8 | MP0008057_abnormal_DNA_replication | 3.33020743 |
| 9 | MP0003123_paternal_imprinting | 3.25035108 |
| 10 | MP0008007_abnormal_cellular_replicative | 2.83279673 |
| 11 | MP0002139_abnormal_hepatobiliary_system | 2.77331970 |
| 12 | MP0008932_abnormal_embryonic_tissue | 2.37594515 |
| 13 | MP0005360_urolithiasis | 2.36034253 |
| 14 | MP0003186_abnormal_redox_activity | 2.32290505 |
| 15 | MP0002396_abnormal_hematopoietic_system | 2.29999763 |
| 16 | MP0005085_abnormal_gallbladder_physiolo | 2.23255719 |
| 17 | MP0001730_embryonic_growth_arrest | 2.20336568 |
| 18 | MP0003718_maternal_effect | 2.16241371 |
| 19 | MP0009379_abnormal_foot_pigmentation | 1.99406066 |
| 20 | MP0005365_abnormal_bile_salt | 1.89268058 |
| 21 | MP0009697_abnormal_copulation | 1.88844178 |
| 22 | MP0000350_abnormal_cell_proliferation | 1.87908126 |
| 23 | MP0006036_abnormal_mitochondrial_physio | 1.87301137 |
| 24 | MP0003786_premature_aging | 1.80966328 |
| 25 | MP0001764_abnormal_homeostasis | 1.63402113 |
| 26 | MP0006035_abnormal_mitochondrial_morpho | 1.61084146 |
| 27 | MP0001697_abnormal_embryo_size | 1.51616264 |
| 28 | MP0001672_abnormal_embryogenesis/_devel | 1.44079757 |
| 29 | MP0005380_embryogenesis_phenotype | 1.44079757 |
| 30 | MP0002080_prenatal_lethality | 1.43026279 |
| 31 | MP0008789_abnormal_olfactory_epithelium | 1.40585998 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.39168320 |
| 33 | MP0008875_abnormal_xenobiotic_pharmacok | 1.39111224 |
| 34 | MP0010352_gastrointestinal_tract_polyps | 1.38110564 |
| 35 | MP0003567_abnormal_fetal_cardiomyocyte | 1.34474867 |
| 36 | MP0003937_abnormal_limbs/digits/tail_de | 1.32370708 |
| 37 | MP0002102_abnormal_ear_morphology | 1.31184057 |
| 38 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30792536 |
| 39 | MP0003315_abnormal_perineum_morphology | 1.29955971 |
| 40 | MP0003984_embryonic_growth_retardation | 1.28824745 |
| 41 | MP0002088_abnormal_embryonic_growth/wei | 1.27372915 |
| 42 | MP0005266_abnormal_metabolism | 1.26704698 |
| 43 | MP0004133_heterotaxia | 1.23211225 |
| 44 | MP0003121_genomic_imprinting | 1.22426312 |
| 45 | MP0000313_abnormal_cell_death | 1.22421580 |
| 46 | MP0006072_abnormal_retinal_apoptosis | 1.22346695 |
| 47 | MP0003890_abnormal_embryonic-extraembry | 1.20209360 |
| 48 | MP0002019_abnormal_tumor_incidence | 1.19894573 |
| 49 | MP0000372_irregular_coat_pigmentation | 1.17503729 |
| 50 | MP0002160_abnormal_reproductive_system | 1.15110051 |
| 51 | MP0000358_abnormal_cell_content/ | 1.14173677 |
| 52 | MP0004197_abnormal_fetal_growth/weight/ | 1.14113488 |
| 53 | MP0000490_abnormal_crypts_of | 1.11050336 |
| 54 | MP0002086_abnormal_extraembryonic_tissu | 1.09618046 |
| 55 | MP0005499_abnormal_olfactory_system | 1.06542934 |
| 56 | MP0005394_taste/olfaction_phenotype | 1.06542934 |
| 57 | MP0002085_abnormal_embryonic_tissue | 1.06292964 |
| 58 | MP0009053_abnormal_anal_canal | 1.06082166 |
| 59 | MP0006292_abnormal_olfactory_placode | 1.05158388 |
| 60 | MP0005332_abnormal_amino_acid | 1.03603712 |
| 61 | MP0002233_abnormal_nose_morphology | 1.01877854 |
| 62 | MP0002132_abnormal_respiratory_system | 1.00539702 |
| 63 | MP0005319_abnormal_enzyme/_coenzyme | 1.00347974 |
| 64 | MP0001188_hyperpigmentation | 0.99308341 |
| 65 | MP0008995_early_reproductive_senescence | 0.99119782 |
| 66 | MP0002210_abnormal_sex_determination | 0.97040144 |
| 67 | MP0002697_abnormal_eye_size | 0.96430295 |
| 68 | MP0001853_heart_inflammation | 0.95705315 |
| 69 | MP0005389_reproductive_system_phenotype | 0.95410320 |
| 70 | MP0002084_abnormal_developmental_patter | 0.95273933 |
| 71 | MP0001293_anophthalmia | 0.95241612 |
| 72 | MP0010307_abnormal_tumor_latency | 0.94848457 |
| 73 | MP0005083_abnormal_biliary_tract | 0.93843136 |
| 74 | MP0010030_abnormal_orbit_morphology | 0.93194553 |
| 75 | MP0001145_abnormal_male_reproductive | 0.89802504 |
| 76 | MP0009672_abnormal_birth_weight | 0.89671341 |
| 77 | MP0010329_abnormal_lipoprotein_level | 0.88565477 |
| 78 | MP0000598_abnormal_liver_morphology | 0.86943944 |
| 79 | MP0005376_homeostasis/metabolism_phenot | 0.86491269 |
| 80 | MP0001119_abnormal_female_reproductive | 0.86103699 |
| 81 | MP0009703_decreased_birth_body | 0.85947960 |
| 82 | MP0004147_increased_porphyrin_level | 0.85800018 |
| 83 | MP0002254_reproductive_system_inflammat | 0.84339880 |
| 84 | MP0005408_hypopigmentation | 0.83437417 |
| 85 | MP0003941_abnormal_skin_development | 0.82174705 |
| 86 | MP0000653_abnormal_sex_gland | 0.79256999 |
| 87 | MP0000537_abnormal_urethra_morphology | 0.78573238 |
| 88 | MP0001529_abnormal_vocalization | 0.77958133 |
| 89 | MP0002163_abnormal_gland_morphology | 0.77780827 |
| 90 | MP0003119_abnormal_digestive_system | 0.77431966 |
| 91 | MP0005501_abnormal_skin_physiology | 0.77012310 |
| 92 | MP0001919_abnormal_reproductive_system | 0.75478081 |
| 93 | MP0009840_abnormal_foam_cell | 0.74836903 |
| 94 | MP0002938_white_spotting | 0.73738925 |
| 95 | MP0005075_abnormal_melanosome_morpholog | 0.73642584 |
| 96 | MP0002796_impaired_skin_barrier | 0.73162211 |
| 97 | MP0002736_abnormal_nociception_after | 0.72625186 |
| 98 | MP0001929_abnormal_gametogenesis | 0.72585117 |
| 99 | MP0005084_abnormal_gallbladder_morpholo | 0.71849293 |
| 100 | MP0002090_abnormal_vision | 0.70632759 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.70194577 |
| 102 | MP0003136_yellow_coat_color | 0.70067605 |
| 103 | MP0002111_abnormal_tail_morphology | 0.69185901 |
| 104 | MP0002751_abnormal_autonomic_nervous | 0.68553674 |
| 105 | MP0002234_abnormal_pharynx_morphology | 0.68155448 |
| 106 | MP0009333_abnormal_splenocyte_physiolog | 0.68026540 |
| 107 | MP0000609_abnormal_liver_physiology | 0.67383431 |
| 108 | MP0000049_abnormal_middle_ear | 0.66359421 |
| 109 | MP0005395_other_phenotype | 0.65868616 |
| 110 | MP0003646_muscle_fatigue | 0.63293654 |
| 111 | MP0001346_abnormal_lacrimal_gland | 0.62962943 |
| 112 | MP0004808_abnormal_hematopoietic_stem | 0.62584290 |
| 113 | MP0001881_abnormal_mammary_gland | 0.60860158 |
| 114 | MP0005367_renal/urinary_system_phenotyp | 0.60627847 |
| 115 | MP0000516_abnormal_urinary_system | 0.60627847 |
| 116 | MP0000689_abnormal_spleen_morphology | 0.60621951 |
| 117 | MP0004019_abnormal_vitamin_homeostasis | 0.60326277 |
| 118 | MP0000647_abnormal_sebaceous_gland | 0.59990983 |
| 119 | MP0005384_cellular_phenotype | 0.58914295 |
| 120 | MP0005636_abnormal_mineral_homeostasis | 0.58422307 |
| 121 | MP0005451_abnormal_body_composition | 0.57764131 |
| 122 | MP0002722_abnormal_immune_system | 0.57458805 |
| 123 | MP0001286_abnormal_eye_development | 0.56304600 |
| 124 | MP0002095_abnormal_skin_pigmentation | 0.55305850 |
| 125 | MP0003698_abnormal_male_reproductive | 0.53766532 |
| 126 | MP0002269_muscular_atrophy | 0.53708757 |
| 127 | MP0001727_abnormal_embryo_implantation | 0.52960775 |
| 128 | MP0004084_abnormal_cardiac_muscle | 0.52786512 |
| 129 | MP0004264_abnormal_extraembryonic_tissu | 0.52332173 |
| 130 | MP0000750_abnormal_muscle_regeneration | 0.51896088 |
| 131 | MP0002161_abnormal_fertility/fecundity | 0.51237871 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Birth length less than 3rd percentile (HP:0003561) | 4.73889563 |
| 2 | Oral leukoplakia (HP:0002745) | 4.24738433 |
| 3 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 4.20383009 |
| 4 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.13767257 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 4.00214342 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 3.68109439 |
| 7 | Reticulocytopenia (HP:0001896) | 3.65848852 |
| 8 | Increased serum pyruvate (HP:0003542) | 3.58331642 |
| 9 | Abnormality of glycolysis (HP:0004366) | 3.58331642 |
| 10 | Abnormality of the labia minora (HP:0012880) | 3.49034435 |
| 11 | Breast hypoplasia (HP:0003187) | 3.40597676 |
| 12 | Colon cancer (HP:0003003) | 3.30535287 |
| 13 | Increased CSF lactate (HP:0002490) | 3.23150435 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.21090455 |
| 15 | Increased serum lactate (HP:0002151) | 3.18457107 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.16862517 |
| 17 | Aplastic anemia (HP:0001915) | 3.14842173 |
| 18 | Hepatic necrosis (HP:0002605) | 3.11210318 |
| 19 | Hepatocellular necrosis (HP:0001404) | 3.03553988 |
| 20 | Degeneration of anterior horn cells (HP:0002398) | 3.02403959 |
| 21 | Abnormality of the anterior horn cell (HP:0006802) | 3.02403959 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.02215830 |
| 23 | Macrocytic anemia (HP:0001972) | 2.99142395 |
| 24 | Mitochondrial inheritance (HP:0001427) | 2.98311087 |
| 25 | Acute encephalopathy (HP:0006846) | 2.98273071 |
| 26 | Cerebral hypomyelination (HP:0006808) | 2.97973157 |
| 27 | Cerebral edema (HP:0002181) | 2.84385009 |
| 28 | Rough bone trabeculation (HP:0100670) | 2.79744612 |
| 29 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.79604968 |
| 30 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.79604968 |
| 31 | Multiple enchondromatosis (HP:0005701) | 2.79471062 |
| 32 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.77857030 |
| 33 | Lipid accumulation in hepatocytes (HP:0006561) | 2.75898254 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 2.73808905 |
| 35 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.71970798 |
| 36 | Microretrognathia (HP:0000308) | 2.68498516 |
| 37 | Carpal bone hypoplasia (HP:0001498) | 2.58336796 |
| 38 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.55104418 |
| 39 | Small intestinal stenosis (HP:0012848) | 2.53347456 |
| 40 | Duodenal stenosis (HP:0100867) | 2.53347456 |
| 41 | Lactic acidosis (HP:0003128) | 2.52750223 |
| 42 | Microvesicular hepatic steatosis (HP:0001414) | 2.47818347 |
| 43 | Progressive macrocephaly (HP:0004481) | 2.47166529 |
| 44 | Patellar aplasia (HP:0006443) | 2.46091575 |
| 45 | Nausea (HP:0002018) | 2.45034058 |
| 46 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.43313030 |
| 47 | Selective tooth agenesis (HP:0001592) | 2.43237455 |
| 48 | Pallor (HP:0000980) | 2.42534633 |
| 49 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.37792516 |
| 50 | Megaloblastic anemia (HP:0001889) | 2.37680641 |
| 51 | Exercise intolerance (HP:0003546) | 2.37254701 |
| 52 | Hyperglycinemia (HP:0002154) | 2.33643499 |
| 53 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.32373723 |
| 54 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.31997447 |
| 55 | Myelodysplasia (HP:0002863) | 2.31491145 |
| 56 | Renal Fanconi syndrome (HP:0001994) | 2.31488178 |
| 57 | Cellular immunodeficiency (HP:0005374) | 2.31252884 |
| 58 | 11 pairs of ribs (HP:0000878) | 2.31110010 |
| 59 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.31108081 |
| 60 | 3-Methylglutaconic aciduria (HP:0003535) | 2.27857498 |
| 61 | Premature graying of hair (HP:0002216) | 2.27457426 |
| 62 | CNS demyelination (HP:0007305) | 2.24634802 |
| 63 | Abnormality of the duodenum (HP:0002246) | 2.23875486 |
| 64 | Medulloblastoma (HP:0002885) | 2.22912542 |
| 65 | Lethargy (HP:0001254) | 2.22357786 |
| 66 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22065099 |
| 67 | Abnormal lung lobation (HP:0002101) | 2.21428638 |
| 68 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.20839316 |
| 69 | Meckel diverticulum (HP:0002245) | 2.19506171 |
| 70 | Type I transferrin isoform profile (HP:0003642) | 2.19351551 |
| 71 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.18161619 |
| 72 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.18161619 |
| 73 | Abnormal protein glycosylation (HP:0012346) | 2.18161619 |
| 74 | Abnormal glycosylation (HP:0012345) | 2.18161619 |
| 75 | Abnormality of the preputium (HP:0100587) | 2.18025251 |
| 76 | Triphalangeal thumb (HP:0001199) | 2.17912310 |
| 77 | Embryonal renal neoplasm (HP:0011794) | 2.16988615 |
| 78 | Poor head control (HP:0002421) | 2.13526834 |
| 79 | Absent radius (HP:0003974) | 2.12843819 |
| 80 | Abnormal trabecular bone morphology (HP:0100671) | 2.11656508 |
| 81 | Agnosia (HP:0010524) | 2.11604857 |
| 82 | Abnormality of the ileum (HP:0001549) | 2.08499155 |
| 83 | Neoplasm of the pancreas (HP:0002894) | 2.08183978 |
| 84 | Secondary amenorrhea (HP:0000869) | 2.07881950 |
| 85 | Abnormality of serum amino acid levels (HP:0003112) | 2.07588639 |
| 86 | Hyperammonemia (HP:0001987) | 2.06827829 |
| 87 | Rhabdomyolysis (HP:0003201) | 2.06366059 |
| 88 | Supernumerary spleens (HP:0009799) | 2.05982826 |
| 89 | Pancytopenia (HP:0001876) | 2.05915030 |
| 90 | Intrahepatic cholestasis (HP:0001406) | 2.05790699 |
| 91 | Leukodystrophy (HP:0002415) | 2.05052304 |
| 92 | Progressive muscle weakness (HP:0003323) | 2.04565554 |
| 93 | Increased intramyocellular lipid droplets (HP:0012240) | 2.04345556 |
| 94 | Horseshoe kidney (HP:0000085) | 2.03882136 |
| 95 | Absent thumb (HP:0009777) | 2.01777587 |
| 96 | Hyperglycinuria (HP:0003108) | 2.00424563 |
| 97 | Ependymoma (HP:0002888) | 2.00402836 |
| 98 | Premature ovarian failure (HP:0008209) | 2.00040127 |
| 99 | Sloping forehead (HP:0000340) | 1.99465798 |
| 100 | Methylmalonic acidemia (HP:0002912) | 1.98987545 |
| 101 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.98769831 |
| 102 | Abnormality of methionine metabolism (HP:0010901) | 1.96471464 |
| 103 | Aplasia involving forearm bones (HP:0009822) | 1.96426925 |
| 104 | Absent forearm bone (HP:0003953) | 1.96426925 |
| 105 | Chromsome breakage (HP:0040012) | 1.96155253 |
| 106 | Bone marrow hypocellularity (HP:0005528) | 1.95564424 |
| 107 | Ragged-red muscle fibers (HP:0003200) | 1.95244227 |
| 108 | Abnormality of chromosome stability (HP:0003220) | 1.94440157 |
| 109 | Neoplasm of the adrenal gland (HP:0100631) | 1.94237159 |
| 110 | Respiratory difficulties (HP:0002880) | 1.93500725 |
| 111 | Abnormality of alanine metabolism (HP:0010916) | 1.92962018 |
| 112 | Hyperalaninemia (HP:0003348) | 1.92962018 |
| 113 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.92962018 |
| 114 | Increased muscle lipid content (HP:0009058) | 1.91563253 |
| 115 | Respiratory failure (HP:0002878) | 1.91253437 |
| 116 | Postnatal microcephaly (HP:0005484) | 1.90700210 |
| 117 | Neoplasm of the colon (HP:0100273) | 1.90580657 |
| 118 | Female pseudohermaphroditism (HP:0010458) | 1.89503408 |
| 119 | Hypolipoproteinemia (HP:0010981) | 1.88973128 |
| 120 | Abnormality of reticulocytes (HP:0004312) | 1.88195481 |
| 121 | Reduced antithrombin III activity (HP:0001976) | 1.87774445 |
| 122 | Impulsivity (HP:0100710) | 1.86265988 |
| 123 | Facial cleft (HP:0002006) | 1.85841102 |
| 124 | Rhabdomyosarcoma (HP:0002859) | 1.84506278 |
| 125 | Abnormality of glycine metabolism (HP:0010895) | 1.82536715 |
| 126 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.82536715 |
| 127 | Delayed CNS myelination (HP:0002188) | 1.81376748 |
| 128 | Emotional lability (HP:0000712) | 1.81069497 |
| 129 | Cleft eyelid (HP:0000625) | 1.80058118 |
| 130 | Sparse eyelashes (HP:0000653) | 1.79768603 |
| 131 | Exertional dyspnea (HP:0002875) | 1.79418233 |
| 132 | Methylmalonic aciduria (HP:0012120) | 1.77446374 |
| 133 | Abnormality of the carotid arteries (HP:0005344) | 1.76780957 |
| 134 | Bifid tongue (HP:0010297) | 1.76270562 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.64080900 |
| 2 | WEE1 | 4.20824973 |
| 3 | EIF2AK1 | 4.19935488 |
| 4 | VRK2 | 3.78117435 |
| 5 | STK16 | 3.59722584 |
| 6 | CDC7 | 3.38944145 |
| 7 | SRPK1 | 3.20376718 |
| 8 | EIF2AK3 | 2.91490497 |
| 9 | TSSK6 | 2.80721081 |
| 10 | NME2 | 2.51599879 |
| 11 | NEK1 | 2.49456354 |
| 12 | PLK4 | 2.49431488 |
| 13 | VRK1 | 2.27565102 |
| 14 | BCKDK | 2.01623428 |
| 15 | TRIM28 | 2.00938806 |
| 16 | MKNK1 | 2.00831127 |
| 17 | BRSK2 | 1.94633018 |
| 18 | PLK3 | 1.82133392 |
| 19 | ACVR1B | 1.79397393 |
| 20 | PLK1 | 1.74117555 |
| 21 | NUAK1 | 1.63998262 |
| 22 | TTK | 1.62550632 |
| 23 | DYRK3 | 1.56954107 |
| 24 | PASK | 1.51915693 |
| 25 | CDK7 | 1.49559138 |
| 26 | TAF1 | 1.48796359 |
| 27 | TESK2 | 1.46341228 |
| 28 | ZAK | 1.46030407 |
| 29 | AURKB | 1.45293123 |
| 30 | PBK | 1.41692469 |
| 31 | RPS6KB2 | 1.41416477 |
| 32 | ATR | 1.35184659 |
| 33 | MKNK2 | 1.30666553 |
| 34 | NEK2 | 1.30602726 |
| 35 | AURKA | 1.30130462 |
| 36 | NME1 | 1.29841131 |
| 37 | FLT3 | 1.27405117 |
| 38 | SCYL2 | 1.27249854 |
| 39 | TLK1 | 1.25656645 |
| 40 | CCNB1 | 1.25474414 |
| 41 | TGFBR1 | 1.25044617 |
| 42 | PIM2 | 1.15872087 |
| 43 | EPHA2 | 1.14490533 |
| 44 | EIF2AK2 | 1.13117298 |
| 45 | BRSK1 | 1.11512756 |
| 46 | BMPR1B | 1.10478022 |
| 47 | RPS6KA4 | 1.06843889 |
| 48 | WNK3 | 1.05236504 |
| 49 | TNIK | 1.04389444 |
| 50 | ALK | 1.01409074 |
| 51 | MAP3K8 | 0.98993722 |
| 52 | KDR | 0.98811300 |
| 53 | BRAF | 0.96489600 |
| 54 | PAK4 | 0.93927420 |
| 55 | CHEK2 | 0.92225076 |
| 56 | CHEK1 | 0.87339651 |
| 57 | CSNK2A2 | 0.86450704 |
| 58 | CDK4 | 0.86192394 |
| 59 | CSNK2A1 | 0.84702084 |
| 60 | TESK1 | 0.84317269 |
| 61 | STK38L | 0.83860622 |
| 62 | OBSCN | 0.79488329 |
| 63 | MAP3K11 | 0.76798341 |
| 64 | ABL2 | 0.76617138 |
| 65 | CDK8 | 0.75985670 |
| 66 | MYLK | 0.73898434 |
| 67 | MAP4K2 | 0.70754444 |
| 68 | CSNK1G1 | 0.70016487 |
| 69 | PNCK | 0.68921423 |
| 70 | DYRK2 | 0.67761776 |
| 71 | PDK3 | 0.66017151 |
| 72 | PDK4 | 0.66017151 |
| 73 | LIMK1 | 0.65685081 |
| 74 | ERBB4 | 0.64793949 |
| 75 | CSNK1G3 | 0.63689240 |
| 76 | AKT3 | 0.61212096 |
| 77 | ATM | 0.60532965 |
| 78 | PAK1 | 0.58086157 |
| 79 | STK4 | 0.57959819 |
| 80 | SMG1 | 0.57728426 |
| 81 | DAPK1 | 0.57164820 |
| 82 | STK3 | 0.56752906 |
| 83 | BCR | 0.56637731 |
| 84 | CDK2 | 0.55863590 |
| 85 | PIM1 | 0.55266487 |
| 86 | TAOK2 | 0.53926481 |
| 87 | FGFR1 | 0.52700928 |
| 88 | PKN2 | 0.51956613 |
| 89 | GRK1 | 0.50987746 |
| 90 | MAP3K12 | 0.47991367 |
| 91 | CLK1 | 0.47449563 |
| 92 | CSNK1A1L | 0.47221196 |
| 93 | PRKCI | 0.46551801 |
| 94 | ARAF | 0.45844037 |
| 95 | MAP2K3 | 0.44825215 |
| 96 | CSNK1G2 | 0.43929068 |
| 97 | PLK2 | 0.42771097 |
| 98 | CDK19 | 0.42659237 |
| 99 | CDK1 | 0.41532448 |
| 100 | YES1 | 0.40545966 |
| 101 | PRKDC | 0.38099673 |
| 102 | ILK | 0.37051634 |
| 103 | CDK6 | 0.36409462 |
| 104 | BRD4 | 0.35405232 |
| 105 | STK24 | 0.35116586 |
| 106 | AKT2 | 0.34748275 |
| 107 | CDK3 | 0.34626626 |
| 108 | CDK9 | 0.34517970 |
| 109 | RPS6KA5 | 0.34133292 |
| 110 | STK10 | 0.31627769 |
| 111 | RAF1 | 0.29658160 |
| 112 | LRRK2 | 0.28846194 |
| 113 | OXSR1 | 0.28550963 |
| 114 | STK39 | 0.27015774 |
| 115 | CSNK1E | 0.25035748 |
| 116 | NEK9 | 0.24510174 |
| 117 | ERBB3 | 0.23666752 |
| 118 | TYK2 | 0.23382995 |
| 119 | MST4 | 0.23156436 |
| 120 | RPS6KB1 | 0.22877969 |
| 121 | MAP3K3 | 0.22101667 |
| 122 | CSNK1A1 | 0.21632537 |
| 123 | MAP2K6 | 0.21608629 |
| 124 | MAP3K5 | 0.21471655 |
| 125 | MAP3K10 | 0.20892378 |
| 126 | MAPKAPK5 | 0.20128196 |
| 127 | GRK6 | 0.19418690 |
| 128 | PDK2 | 0.18554909 |
| 129 | RPS6KL1 | 0.18515083 |
| 130 | RPS6KC1 | 0.18515083 |
| 131 | TEC | 0.18473281 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.18269970 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 4.09884561 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.59121533 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.45943543 |
| 5 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.15071438 |
| 6 | RNA polymerase_Homo sapiens_hsa03020 | 2.98842579 |
| 7 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.72799757 |
| 8 | Spliceosome_Homo sapiens_hsa03040 | 2.65225653 |
| 9 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.46925747 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 2.44015055 |
| 11 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.43491174 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.42846617 |
| 13 | Base excision repair_Homo sapiens_hsa03410 | 2.37666963 |
| 14 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.31268761 |
| 15 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.83943026 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 1.71533044 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.66273631 |
| 18 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.61819331 |
| 19 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.61282309 |
| 20 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.57403894 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56660251 |
| 22 | RNA degradation_Homo sapiens_hsa03018 | 1.56031140 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54072008 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.47669976 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.45827225 |
| 26 | Parkinsons disease_Homo sapiens_hsa05012 | 1.42908905 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40722122 |
| 28 | Basal transcription factors_Homo sapiens_hsa03022 | 1.39385789 |
| 29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.39052226 |
| 30 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.38403490 |
| 31 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.37160277 |
| 32 | Purine metabolism_Homo sapiens_hsa00230 | 1.24954463 |
| 33 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.24485948 |
| 34 | Huntingtons disease_Homo sapiens_hsa05016 | 1.20037603 |
| 35 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.18643909 |
| 36 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.18501121 |
| 37 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.15036501 |
| 38 | Sulfur relay system_Homo sapiens_hsa04122 | 1.09665546 |
| 39 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.09291741 |
| 40 | Protein export_Homo sapiens_hsa03060 | 1.08475174 |
| 41 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.07747253 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06588205 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.06331975 |
| 44 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06166394 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.98576910 |
| 46 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.93306164 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.93098744 |
| 48 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.91271043 |
| 49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.91188864 |
| 50 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.88035286 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.86761940 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.82929933 |
| 53 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82465693 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80970938 |
| 55 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77713217 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.75363248 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.74969516 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72678258 |
| 59 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70070826 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68892669 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.67414549 |
| 62 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.67388744 |
| 63 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67032600 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.66198424 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66133602 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.65921697 |
| 67 | Metabolic pathways_Homo sapiens_hsa01100 | 0.64556094 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63353427 |
| 69 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.62770417 |
| 70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62521112 |
| 71 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61146785 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.60687721 |
| 73 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.58018531 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56718543 |
| 75 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56224763 |
| 76 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52647261 |
| 77 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.52446316 |
| 78 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.49806181 |
| 79 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47341920 |
| 80 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44343404 |
| 81 | Retinol metabolism_Homo sapiens_hsa00830 | 0.43856992 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.42143487 |
| 83 | Legionellosis_Homo sapiens_hsa05134 | 0.39742069 |
| 84 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.38870420 |
| 85 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.37555769 |
| 86 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.36032541 |
| 87 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34803699 |
| 88 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.34620305 |
| 89 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.33918320 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.33027518 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.31749005 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.30009591 |
| 93 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.29987844 |
| 94 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.28554550 |
| 95 | Thyroid cancer_Homo sapiens_hsa05216 | 0.26735735 |
| 96 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25296091 |
| 97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25098191 |
| 98 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.21840814 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.21701272 |
| 100 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.19549625 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19209995 |
| 102 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.19209320 |
| 103 | Lysine degradation_Homo sapiens_hsa00310 | 0.18531322 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.16987877 |
| 105 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.14883302 |
| 106 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.13914770 |
| 107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.12048593 |
| 108 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.11899876 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.09675580 |
| 110 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.09362108 |

